Pharmacological benefits of agomelatine and vanillin in experimental model of Huntington's disease

Pharmacology Biochemistry and Behavior

Volumn 122, Issue , 2014, Pages 122-135

  Gupta, Surbhi ^a   Sharma, Bhupesh ^a,b  

^a BHARAT INSTITUTE OF TECHNOLOGY   (India)

^b Dilshad Garden   (India)

Author keywords

3 Nitropropionic acid; Acetylcholinesterase; Mitochondrial enzyme complex; Morris water maze; Oxidative stress; Tetrabenazine

Indexed keywords

3 NITROPROPIONIC ACID; AGOMELATINE; CATALASE; GLUTATHIONE; MITOCHONDRIAL ENZYME; NITRATE; NITRITE; SUPEROXIDE DISMUTASE; TETRABENAZINE; VANILLIN; 3-NITROPROPIONIC ACID; ACETAMIDE DERIVATIVE; BENZALDEHYDE DERIVATIVE; MELATONIN; NITRO DERIVATIVE; PROPIONIC ACID DERIVATIVE; TRPV1 PROTEIN, RAT; VANILLOID RECEPTOR;

ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; CORPUS STRIATUM; DISEASE COURSE; FEMALE; HUNTINGTON CHOREA; LEARNING; LIPID PEROXIDATION; LOCOMOTION; MALE; MEMORY; MORRIS WATER MAZE TEST; MOTOR COORDINATION; NITROSATIVE STRESS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; SEX DIFFERENCE; WEIGHT REDUCTION; AGONISTS; ANIMAL; CHEMICALLY INDUCED; DISEASE MODEL; DRUG EFFECTS; HUNTINGTON DISEASE; MAZE TEST; MOTOR ACTIVITY; PATHOLOGY; PHYSIOLOGY; TOXICITY; WISTAR RAT;

ACETAMIDES; ANIMALS; BENZALDEHYDES; DISEASE MODELS, ANIMAL; FEMALE; HUNTINGTON DISEASE; MALE; MAZE LEARNING; MELATONIN; MOTOR ACTIVITY; NITRO COMPOUNDS; PROPIONATES; RATS; RATS, WISTAR; TRPV CATION CHANNELS;

EID: 84898912144     PISSN: 00913057     EISSN: 18735177     Source Type: Journal    
DOI: 10.1016/j.pbb.2014.03.022     Document Type: Article

References (88)

1. H. Aebi Catalase in vitro Methods Enzymol 105 1984 121 126
2. A. Afrasiabi, G.H. Riazi, S. Abbasi, A. Dadras, B. Ghalandari, and H. Seidkhani et al. Synaptosomal acetylcholinesterase activity variation pattern in the presence of electromagnetic fields Int J Biol Macromol 65C 2014 8 15
3. R. Agrawal, E. Tyagi, R. Shukla, and C. Nath Effect of insulin and melatonin on acetylcholinesterase activity in the brain of amnesic mice Behav Brain Res 189 2008 381 386
4. D.R. Andersson, H. Nissbrandt, and F. Bergquist Partial depletion of dopamine in substantia nigra impairs motor performance without altering striatal dopamine neurotransmission Eur J Neurosci 24 2006 617 624 (Pubitemid 44100353)
5. C. Beauchamp, and I. Fridovich Superoxide dismutase: improved assays and an assay applicable to acrylamide gels Anal Biochem 44 1971 276 287
6. D. Bennion, T. Jensen, C. Walther, J. Hamblin, A. Wallmann, and J. Couch et al. Transient receptor potential vanilloid 1 agonists modulate hippocampal CA1 LTP via the GABAergic system Neuropharmacology 61 2011 730 738
7. S.B. Berman, and T.G. Hastings Dopamine oxidation alters mitochondrial respiration and induces permeability transition in brain mitochondria: implications for Parkinson's disease J Neurochem 73 1999 1127 1137 (Pubitemid 29395471)
8. A. Bertoni, P. Giuliano, M. Galgani, D. Rotoli, L. Ulianich, and A. Adornetto et al. Early and late events induced by polyQ-expanded proteins: identification of a common pathogenic property of polYQ-expanded proteins J Biol Chem 286 2011 4727 4741
9. D.K. Bhateja, D.K. Dhull, A. Gill, A. Sidhu, S. Sharma, and B.V. Reddy et al. Peroxisome proliferator-activated receptor-α activation attenuates 3-nitropropionic acid induced behavioral and biochemical alterations in rats, possible neuroprotective mechanisms Eur J Pharmacol 674 2012 33 43
10. Y. Binawade, and A. Jagtap Neuroprotective effect of lutein against 3-nitropropionic acid-induced Huntington's disease-like symptoms: possible behavioral, biochemical, and cellular alterations J Med Food 16 2013 934 943
11. E. Brouillet, B.G. Jenkins, B.T. Hyman, R.J. Ferrante, N.W. Kowall, and R. Srivastava et al. Age-dependent vulnerability of the striatum to the mitochondrial toxin 3-nitropropionic acid J Neurochem 60 1993 356 359 (Pubitemid 23006739)
12. P. Calabresi, P. Gubellini, B. Picconi, D. Centonze, A. Pisani, and P. Bonsi et al. Inhibition of mitochondrial complex II induces a long-term potentiation of NMDA-mediated synaptic excitation in the striatum requiring endogenous dopamine J Neurosci 21 2001 5110 5120 (Pubitemid 32622936)
13. J.J. Chen, W.G. Ondo, K. Dashtipour, and D.M. Swope Tetrabenazine for the treatment of hyperkinetic movement disorders: a review of the literature Clin Ther 34 2012 1487 1504
14. J. Chen, L. Wang, C. Wu, Q. Hu, C. Gu, and F. Yan et al. Melatonin-enhanced autophagy protects against neural apoptosis via a mitochondrial pathway in early brain injury following a subarachnoid hemorrhage J Pineal Res 2013 10.1111/jpi.12086
15. F. Chenu, M. El Mansari, and P. Blier Electrophysiological effects of repeated administration of agomelatine on the dopamine, norepinephrine, and serotonin systems in the rat brain Neuropsychopharmacology 38 2013 275 284
16. K.M. Chu, M.P. Ngan, M.K. Wai, C.K. Yeung, P.L. Andrews, N. Percie du Sert, G. Lin, and J.A. Rudd Olvanil, a non-pungent vanilloid enhances the gastrointestinal toxicity of cisplatin in the ferret Toxicol Lett 192 2010 402 407
17. D. Colle, D.B. Santos, E.L. Moreira, J.M. Hartwig, A.A. Dos Santos, and L.T. Zimmermann et al. Probucol increases striatal glutathione peroxidase activity and protects against 3-nitropropionic acid-induced pro-oxidative damage in rats PLoS One 8 2013 e67658
18. L. Conboy, C. Tanrikut, P.R. Zoladz, A.M. Campbell, C.R. Park, and C. Gabriel et al. The antidepressant agomelatine blocks the adverse effects of stress on memory and enables spatial learning to rapidly increase neural cell adhesion molecule (NCAM) expression in the hippocampus of rats Int J Neuropsychopharmacol 12 2009 329 341
19. A. Corrales, R. Vidal, S. García, V. Vidal, P. Martínez, and E. García et al. Chronic melatonin treatment rescues electrophysiological and neuromorphological deficits in a mouse model of Down syndrome J Pineal Res 56 2014 51 61
20. G. Dagyte, P.G. Luiten, T. De Jager, C. Gabriel, E. Mocaër, and J.A. Den Boer et al. Chronic stress and antidepressant agomelatine induce region-specific changes in synapsin I expression in the rat brain J Neurosci Res 89 2011 1646 1657
21. A. Dalbem, C.V. Silveira, M.F. Pedroso, R.V. Breda, C.V. Werne Baes, and A.P. Bartmann et al. Altered distribution of striatal activity-dependent synaptic plasticity in the 3-nitropropionic acid model of Huntington's disease Brain Res 1047 2005 148 158 (Pubitemid 40799310)
22. A. Das, M. McDowell, M.J. Pava, J.A. Smith, R.J. Reiter, and J.J. Woodward et al. The inhibition of apoptosis by melatonin in VSC4.1 motoneurons exposed to oxidative stress, glutamate excitotoxicity, or TNF-alpha toxicity involves membrane melatonin receptors J Pineal Res 48 2010 157 169
23. K. Demyttenaere Agomelatine: a narrative review Eur Neuropsychopharmacol 21 2011 S703 S709
24. A.M. Farrar, J.W. Callahan, and E.D. Abercrombie Reduced striatal acetylcholine efflux in the R6/2 mouse model of Huntington's disease: an examination of the role of altered inhibitory and excitatory mechanisms Exp Neurol 232 2011 119 125
25. J. Fernández-Ruiz, and S. Gonzáles Cannabinoid control of motor function at the basal ganglia Handb Exp Pharmacol 168 2005 479 507
26. M. Forster, A. Dubey, K. Dawson, W. Stutts, H. Lal, and R. Sohal Age-related losses of cognitive function and motor skills in mice are associated with oxidative protein damage in the brain Proc Natl Acad Sci U S A 88 1996 3633 3636
27. S. Frank Tetrabenazine as anti-chorea therapy in Huntington disease: an open-label continuation study. Huntington Study Group/TETRA-HD Investigators BMC Neurol 9 2009 62
28. K. Gopinath, and G. Sudhandiran Naringin modulates oxidative stress and inflammation in 3-nitropropionic acid-induced neurodegeneration through the activation of nuclear factor-erythroid 2-related factor-2 signalling pathway Neuroscience 227 2012 134 143
29. Y. Gros, and S. Schuldiner Directed evolution reveals hidden properties of VMAT, a neurotransmitter transporter J Biol Chem 285 2010 5076 5084
30. F. Grotenhermen Pharmacology of cannabinoids Neuro Endocrinol Lett 25 1-2 2004 14 23 (Pubitemid 44783352)
31. L. Guermonprez, C. Ducrocq, and Y.M. Gaudry-Talarmain Inhibition of acetylcholine synthesis and tyrosine nitration induced by peroxynitrite are differentially prevented by antioxidants Mol Pharmacol 60 2001 838 846 (Pubitemid 32900267)
32. S. Gupta, and B. Sharma Pharmacological modulation of I1-imidazoline and α2-adrenoceptors in sub acute brain ischemia induced vascular dementia Eur J Pharmacol 15 723 2014 80 90
33. I. Han, Y. You, J.H. Kordower, S.T. Brady, and G.A. Morfini Differential vulnerability of neurons in Huntington's disease: the role of cell type-specific features J Neurochem 113 2010 1073 1091
34. R. Hardeland Melatonin in aging and disease -multiple consequences of reduced secretion, options and limits of treatment Aging Dis 3 2012 194 225
35. R. Hardeland, and B. Poeggeler Melatonin and synthetic melatonergic agonists: actions and metabolism in the central nervous system Cent Nerv Syst Agents Med Chem 12 2012 189 216
36. J.P. Kamat, A. Ghosh, and T.P. Devasagayam Vanillin as an antioxidant in rat liver mitochondria: inhibition of protein oxidation and lipid peroxidation induced by photosensitization Mol Cell Biochem 209 2000 47 53 (Pubitemid 30451434)
37. R.K. Kharwar, and C. Haldar Daily variation in antioxidant enzymes and lipid peroxidation in lungs of a tropical bird Perdicula asiatica: role of melatonin and nuclear receptor RORα Comp Biochem Physiol A Mol Integr Physiol 162 2012 296 302
38. T.E. King Preparation of succinate dehydrogenase and reconstitution of succinate oxidase Methods Enzymol 10 1967 322 331
39. T.E. King, and R.L. Howard Preparations and properties of soluble NADH dehydrogenases from cardiac muscle Methods Enzymol 10 1967 275 284
40. M. Konagaya, Y. Konagaya, and M. Iida CSF acetylcholinesterase activity in central neurological diseases involving cholinergic systems Rinsho Shinkeigaku 32 1992 266 271
41. P. Kumar, and A. Kumar Prolonged pretreatment with carvedilol prevents 3-nitropropionic acid-induced behavioral alterations and oxidative stress in rats Pharmacol Rep 5 2008 706 715
42. A. Kumar, and A. Singh Possible involvement of GABAergic mechanism in protective effect of melatonin against sleep deprivation-induced behaviour modification and oxidative damage in mice Fundam Clin Pharmacol 23 2009 439 448
43. P. Kumar, H. Kalonia, and A. Kumar Role of LOX/COX pathways in 3-nitropropionic acid-induced Huntington's disease-like symptoms in rats: protective effect of licofelone Br J Pharmacol 164 2011 644 654
44. A. Kundu, and A. Mitra Flavoring extracts of Hemidesmus indicus roots and Vanilla planifolia pods exhibit in vitro acetylcholinesterase inhibitory activities Plant Foods Hum Nutr 68 2013 247 253
45. C.H. Lee, K.Y. Yoo, J.H. Choi, O.K. Park, I.K. Hwang, and Y.G. Kwon et al. Melatonin's protective action against ischemic neuronal damage is associated with up-regulation of the MT2 melatonin receptor J Neurosci Res 88 2010 2630 2640
46. H.B. Li, R.R. Mao, J.C. Zhang, Y. Yang, J. Cao, and L. Xu Antistress effect of TRPV1 channel on synaptic plasticity and spatial memory Biol Psychiatry 64 2008 286 292
47. L. Lin, Q.X. Huang, S.S. Yang, J. Chu, J.Z. Wang, and Q. Tian Melatonin in Alzheimer's disease Int J Mol Sci 14 2013 14575 14593
48. Z. Luo, L. Ma, Z. Zhao, H. He, D. Yang, and X. Feng et al. TRPV1 activation improves exercise endurance and energy metabolism through PGC-1α upregulation in mice Cell Res 22 2012 551 564
49. M. Makni, Y. Chtourou, E.M. Garoui, T. Boudawara, and H. Fetoui Carbon tetrachloride-induced nephrotoxicity and DNA damage in rats: protective role of vanillin Hum Exp Toxicol 31 2012 844 852
50. B.S. Mandavilli, I. Van Boldogh, and B. Houten 3-Nitropropionic acid-induced hydrogen peroxide, mitochondrial DNA damage, and cell death are attenuated by Bcl-2 overexpression in PC12 cells Brain Res Mol Brain Res 133 2005 215 223 (Pubitemid 40248412)
51. A.C. Meyer, D.B. Horton, N.M. Neugebauer, T.E. Wooters, J.R. Nickell, and L.P. Dwoskin et al. Tetrabenazine inhibition of monoamine uptake and methamphetamine behavioral effects: locomotor activity, drug discrimination and self-administration Neuropharmacology 61 2011 849 856
52. E. Milusheva, B. Sperlágh, L. Shikova, M. Baranyi, L. Tretter, and V. Adám-Vizi et al. Non-synaptic release of [3H]noradrenaline in response to oxidative stress combined with mitochondrial dysfunction in rat hippocampal slices Neuroscience 120 2003 771 781 (Pubitemid 36928074)
53. J.M. Monti, H. Jantos, and D. Monti Evidence of melatonin involvement in pindolol-induced suppression of REM sleep J Neural Transm 108 2001 1 9 (Pubitemid 32692609)
54. A. Musella, V. De Chiara, S. Rossi, F. Cavasinni, M. Castelli, and C. Cantarella et al. Transient receptor potential vanilloid 1 channels control acetylcholine/2-arachidonoylglicerol coupling in the striatum Neuroscience 167 2010 864 871
55. D. Pala, A. Lodola, A. Bedini, G. Spadoni, and S. Rivara Homology models of melatonin receptors: challenges and recent advances Int J Mol Sci 14 2013 8093 8121
56. M. Pandey, M. Varghese, K.M. Sindhu, S. Sreetama, A.K. Navneet, and K.P. Mohanakumar et al. Mitochondrial NAD +-linked State 3 respiration and complex-I activity are compromised in the cerebral cortex of 3-nitropropionic acid-induced rat model of Huntington's disease J Neurochem 104 2008 420 434 (Pubitemid 350293876)
57. S. Papapetropoulos, and C. Singer Eating dysfunction associated with oromandibular dystonia: clinical characteristics and treatment considerations Head Face Med 2 2006 47
58. L. Pecze, W. Blum, and B. Schwaller Mechanism of capsaicin receptor TRPV1-mediated toxicity in pain-sensing neurons focusing on the effects of Na(+)/Ca(2 +) fluxes and the Ca(2 +)-binding protein calretinin Biochim Biophys Acta 2012 10.1016/j.bbamcr.2012.08.018 [pii: S0167-4889(12)00252-2]
59. V. Popovic, M. Svetel, M. Djurovic, S. Petrovic, M. Doknic, S. Pekic, D. Miljic, N. Milic, J. Glodic, C. Dieguez, F.F. Casanueva, and V. Kostic Circulating and cerebrospinal fluid ghrelin and leptin: potential role in altered body weight in Huntington's disease Eur J Endocrinol 151 4 2004 Oc 451 455 (Pubitemid 39430262)
60. M.A. Pouladi, A.J. Morton, and M.R. Hayden Choosing an animal model for the study of Huntington's disease Nat Rev Neurosci 14 2013 708 721
61. B.D. Przybyla-Zawislak, B.T. Thorn, S.F. Ali, R.A. Dennis, A. Amato, and A. Virmani et al. Identification of rat hippocampal mRNAs altered by the mitochondrial toxicant, 3-NPA Ann N Y Acad Sci 1053 2005 162 173 (Pubitemid 43031094)
62. A.M. Ray, C.D. Benham, J.C. Roberts, C.H. Gill, C. Lanneau, and D.P. Gitterman et al. Capsazepine protects against neuronal injury caused by oxygen glucose deprivation by inhibiting I(h) J Neurosci 23 2003 10146 10153 (Pubitemid 37392563)
63. S. Reuss, U. Disque-Kaiser, U. Binzen, W. Greffrath, and E. Peschke 'TRPing' synaptic ribbon function in the rat pineal gland: neuroendocrine regulation involves the capsaicin receptor TRPV1 Neuroendocrinology 92 2010 133 142
64. R. Sandhir, A. Sood, A. Mehrotra, and S.S. Kamboj N-Acetylcysteine reverses mitochondrial dysfunctions and behavioral abnormalities in 3-nitropropionic acid-induced Huntington's disease Neurodegener Dis 9 2012 145 157
65. T. Schilling, and C. Eder Importance of the non-selective cation channel TRPV1 for microglial reactive oxygen species generation J Neuroimmunol 216 2009 118 121
66. B. Schmelting, S. Corbach-Söhle, S. Kohlhause, C. Schlumbohm, G. Flügge, and E. Fuchs Agomelatine in the tree shrew model of depression: effects on stress-induced nocturnal hyperthermia and hormonal status Eur Neuropsychopharmacol 2013 10.1016/j.euroneuro.2013.07.010 [pii: S0924-977X(13)00210-1]
67. B. Sharma, and N. Singh Attenuation of vascular dementia by sodium butyrate in streptozotocin diabetic rats Psychopharmacology (Berl) 215 2011 677 687
68. B. Sharma, and N. Singh Defensive effect of natrium diethyldithiocarbamate trihydrate (NDDCT) and lisinopril in DOCA-salt hypertension-induced vascular dementia in rats Psychopharmacology (Berl) 223 2012 307 317
69. B. Sharma, and N. Singh Pharmacological inhibition of inducible nitric oxide synthase (iNOS) and nicotinamide adenine dinucleotide phosphate (NADPH) oxidase, convalesce behavior and biochemistry of hypertension induced vascular dementia in rats Pharmacol Biochem Behav 103 2013 821 830
70. B. Sharma, N. Singh, and M. Singh Modulation of celecoxib- and streptozotocin-induced experimental dementia of Alzheimer's disease by pitavastatin and donepezil J Psychopharmacol 22 2008 162 171 (Pubitemid 351322854)
71. A. Shirazi, E. Mihandoost, G. Ghobadi, M. Mohseni, and M. Ghazi-Khansari Evaluation of radio-protective effect of melatonin on whole body irradiation induced liver tissue damage Cell J 14 2013 292 297
72. B.D. Shivasharan, P. Nagakannan, B.S. Thippeswamy, V.P. Veerapur, P. Bansal, and M.K. Unnikrishnan Protective effect of Calendula officinalis Linn. flowers against 3-nitropropionic acid induced experimental Huntington's disease in rats Drug Chem Toxicol 36 2013 466 473
73. D. Sokolovic, B. Djordjevic, G. Kocic, P. Babovic, G. Ristic, and Z. Stanojkovic et al. The effect of melatonin on body mass and behaviour of rats during an exposure to microwave radiation from mobile phone Bratisl Lek Listy 113 2012 265 269
74. R. Soto-Moyano, H. Burgos, F. Flores, L. Valladares, W. Sierralta, and V. Fernández et al. Melatonin administration impairs visuo-spatial performance and inhibits neocortical long-term potentiation in rats Pharmacol Biochem Behav 85 2006 408 414 (Pubitemid 44881082)
75. G.L. Sottocasa, B. Kuylenstierna, L. Ernster, and A. Bergstrand An electron-transport system associated with the outer membrane of liver mitochondria. A biochemical and morphological study J Cell Biol 32 1967 415 438
76. V. Srinivasan, S.R. Pandi-Perumal, G.J. Maestroni, A.I. Esquifino, R. Hardeland, and D.P. Cardinali Role of melatonin in neurodegenerative diseases Neurotox Res 7 2005 293 318
77. T. Sumathi, D. Asha, S.N. Suganya, K. Prasanna, and K. Mohanan Sandhya Neuroprotective activity of l-theanine on 3-nitropropionic acid induced neurotoxicity in rat striatum Int J Neurosci 2013 10.3109/00207454.2013.872642 [PMID: 24325390]
78. A. Suri, and A. Szallasi The emerging role of TRPV1 in diabetes and obesity Trends Pharmacol Sci 29 2008 29 36
79. A. Tai, T. Sawano, F. Yazama, and H. Ito Evaluation of antioxidant activity of vanillin by using multiple antioxidant assays Biochim Biophys Acta 1810 2011 170 177
80. D. Tardito, R. Molteni, M. Popoli, and G. Racagni Synergistic mechanisms involved in the antidepressant effects of agomelatine Eur Neuropsychopharmacol 22 2012 S482 S486
81. X. Wang, A. Sirianni, Z. Pei, K. Cormier, K. Smith, and J. Jiang et al. The melatonin MT1 receptor axis modulates mutant Huntingtin-mediated toxicity J Neurosci 31 2011 14496 14507
82. F. Wang, X. Tian, L. Zhang, D. Tan, R.J. Reiter, and G. Liu Melatonin promotes the in vitro development of pronuclear embryos and increases the efficiency of blastocyst implantation in murine J Pineal Res 55 2013 267 274
83. P. Weydt, V.V. Pineda, A.E. Torrence, R.T. Libby, T.F. Satterfield, and E.R. Lazarowski et al. Thermoregulatory and metabolic defects in Huntington's disease transgenic mice implicate PGC-1alpha in Huntington's disease neurodegeneration Cell Metab 4 2006 349 362 (Pubitemid 44645069)
84. S.L. Wu, J.C. Chen, C.C. Li, H.Y. Lo, T.Y. Ho, and C.Y. Hsiang Vanillin improves and prevents trinitrobenzene sulfonic acid-induced colitis in mice J Pharmacol Exp Ther 330 2009 370 376
85. Y.R. Yang, H.C. Chang, P.S. Wang, and R.Y. Wang Motor performance improved by exercises in cerebral ischemic rats J Mot Behav 44 2012 97 103
86. Y. Yang, W. Duan, Z. Jin, W. Yi, J. Yan, and S. Zhang et al. JAK2/STAT3 activation by melatonin attenuates the mitochondrial oxidative damage induced by myocardial ischemia/reperfusion injury J Pineal Res 55 2013 275 286
87. I.J. You, Y.H. Jung, M.J. Kim, S.H. Kwon, S.I. Hong, and S.Y. Lee et al. Alterations in the emotional and memory behavioral phenotypes of transient receptor potential vanilloid type 1-deficient mice are mediated by changes in expression of 5-HTA, GABA(A), and NMDA receptors Neuropharmacology 62 2012 1034 1043
88. Y. Zhang, A. Cook, J. Kim, S.V. Baranov, J. Jiang, and K. Smith et al. Melatonin inhibits the caspase-1/cytochrome c/caspase-3 cell death pathway, inhibits MT1 receptor loss and delays disease progression in a mouse model of amyotrophic lateral sclerosis Neurobiol Dis 2013 10.1016/j.nbd.2013.03.008 [Mar 26. pii: S0969-9961(13)00096-X]